Abstract: A compound represented by the following general formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition thereof, and the use thereof to prevent or treat infectious diseases and a method to prevent or treat infectious diseases using those regimen are disclosed. The compound represented by formula (I) has an antibacterial activity against both gram-positive and gram-negative bacteria, and is useful in the prevention or treatment of infectious diseases caused by these bacteria.

Abstract: A screening method according to the present invention is a screening method for screening a sheet-type battery, including a charging/discharging waveform acquisition step of acquiring a charging/discharging waveform of the sheet-type battery by charging and discharging the sheet-type battery, a step of evaluating a variation in discharging voltage over time during discharging in the sheet-type battery based on the charging/discharging waveform, a step of evaluating a variation in charging voltage over time during charging in the sheet-type battery based on the charging/discharging waveform, a step of evaluating charging efficiency of the sheet-type battery based on the charging/discharging waveform, a step of evaluating a current value at an end of the charging the sheet-type battery based on the charging/discharging waveform, and a screening step of screening the sheet-type battery based on evaluation results of the steps.

Abstract: A compound represented by the following general formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition thereof, and the use thereof to prevent or treat infectious diseases and a method to prevent or treat infectious diseases using those regimen are disclosed. The compound represented by formula (I) has an antibacterial activity against both gram-positive and gram-negative bacteria, and is useful in the prevention or treatment of infectious diseases caused by these bacteria.

Abstract: A compound represented by the following general formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition thereof, and the use thereof to prevent or treat infectious diseases and a method to prevent or treat infectious diseases using those regimen are disclosed. The compound represented by formula (I) has an antibacterial activity against both gram-positive and gram-negative bacteria, and is useful in the prevention or treatment of infectious diseases caused by these bacteria.

Abstract: A compound represented by the following general formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition thereof, and the use thereof to prevent or treat infectious diseases and a method to prevent or treat infectious diseases using those regimen are disclosed. The compound represented by formula (I) has an antibacterial activity against both gram-positive and gram-negative bacteria, and is useful in the prevention or treatment of infectious diseases caused by these bacteria.

Abstract: A laminated battery according to the present invention is a secondary battery where a first sheet battery, a second sheet battery, a third sheet battery, and a fourth sheet battery are laminated in this order. When an X-Y plane is viewed from above, a tab part of the first sheet battery is placed projecting outward of the sheet battery, and a tab part of the fourth sheet battery is placed projecting outward of the third sheet battery. A second electrode on a surface of the first tab part and a second electrode on a surface of the fourth tab part tab part, are placed face-to-face with each other and connected.

Abstract: The present application provides novel compounds having anti-cancer or anti-Helicobacter pylori activity, pharmaceutical compositions and method for producing and using the novel compound.

Abstract: The present application provides novel compounds having anti-cancer or anti-Helicobacter pylori activity, pharmaceutical compositions and method for producing and using the novel compound.

Abstract: A compound represented by the following general formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition thereof, and the use thereof to prevent or treat infectious diseases and a method to prevent or treat infectious diseases using those regimen are disclosed. The compound represented by formula (I) has an antibacterial activity against both gram-positive and gram-negative bacteria, and is useful in the prevention or treatment of infectious diseases caused by these bacteria.

Abstract: The present application provides novel compounds having anti-cancer or anti-Helicobacter pylori activity, pharmaceutical compositions and method for producing and using the novel compound.

Abstract: A compound expressed by any one of Structural Formulas (1) to (13), a method for producing the same, and a compound-containing composition, an anti-cancer agent, and an anti-Helicobacter pylori agent each containing the above compound.

Abstract: A drug combination against acid-fast bacillus, including: an inhibitor for WecA or an ortholog thereof; and at least one of an inhibitor for MurX or an ortholog thereof and an RNA synthesis inhibitor, wherein the inhibitor for WecA or an ortholog thereof is used in combination with the at least one of an inhibitor for MurX or an ortholog thereof and an RNA synthesis inhibitor; a screening method for a drug against acid-fast bacillus; and an inhibitor for WecA or an ortholog thereof.

Abstract: A compound expressed by any one of Structural Formulas (1) to (13), a method for producing the same, and a compound-containing composition, an anti-cancer agent, and an anti-Helicobacter pylori agent each containing the above compound.

Abstract: The present application provides novel compounds having anti-cancer or anti-Helicobacter pylori activity, pharmaceutical compositions and method for producing and using the novel compound.

Abstract: A method for producing a compound represented by Structural Formula (1), including: introducing benzyl group into trehalose to produce at least one of compound represented by Structural Formula 4a and compound represented by Structural Formula 4a?; subjecting at least one of the Structural Formula 4a compound and the Structural Formula 4a? compound to prenylation to produce at least one of compound represented by Structural Formula 3a and compound represented by Structural Formula 3a?; subjecting at least one of the Structural Formula 3a compound and the Structural Formula 3a? compound to sharpless asymmetric dihydroxylation to produce at least one of compound represented by Structural Formula 2a and compound represented by Structural Formula 2a?; and allowing at least one of the Structural Formula 2a compound and the Structural Formula 2a? compound to react with hydrogen in the presence of palladium catalyst to produce the compound represented by Structural Formula (1).

Abstract: The present invention provides compounds belonging to 3-acyloxyindole compounds or 3-acyl-4-hydroxycoumarin compounds, a tautomer or geometric isomer thereof, or a salt thereof and methods for producing the same, which compounds are useful as antibacterial agent and as therapeutic drugs against infectious diseases.

Abstract: Provided is a multiplex pipe and a system for recovering steam from a geothermal well, which are capable of solving all of the various problems with a neutralization pipe prepared by painting or the like of an alkali-resistant coating on the inner face of an acid-resistant single pipe. A multiplex pipe 10 that is configured to recover steam from a geothermal well GT, includes: a casing pipe 1 located outside; and a duplex pipe 4 that is slidable relative to the casing pipe 1 in the casing pipe 1, and has a first gap 5 with an inner face of the casing pipe 1, the duplex pipe including an outer pipe 2 having acid-resistance and an inner pipe 3 having alkali-resistance, the outer pipe 2 and the inner pipe 3 defining a second gap 6 therebetween.

Abstract: A drug combination against acid-fast bacillus, including: an inhibitor for WecA or an ortholog thereof; and at least one of an inhibitor for MurX or an ortholog thereof and an RNA synthesis inhibitor, wherein the inhibitor for WecA or an ortholog thereof is used in combination with the at least one of an inhibitor for MurX or an ortholog thereof and an RNA synthesis inhibitor; a screening method for a drug against acid-fast bacillus; and an inhibitor for WecA or an ortholog thereof.

Abstract: The present application provides novel compounds having anti-cancer or anti-Helicobacter pylori activity, pharmaceutical compositions and method for producing and using the novel compound.

Abstract: Slightly above a rupture-intended line, a peripheral surface of a projection portion of a stopper cap is pushed in a direction from an outer side to an inner side (in an arrow direction). The stopper cap is pushed over on the principle of leverage in an oblique direction with, as a fulcrum P, the side (the back side) opposite in a circumferential direction to the side (the near side) at which a pushing force PW acts, so that an intermittent portion is ruptured due to bending of the flexible stopper cap. Then, a residual area remains at the syringe side, and a separation area is separated together with the stopper cap from the syringe to perform unsealing. Thus, a syringe label which allows for easy unsealing along the intermittent portion and with which an unsealed state is easily confirmed, and a drug solution-filled syringe using the label, are provided.